McGann PT - Search Results

1

Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.

Dong M, McGann PT. Dong M, et al. Among authors: mcgann pt. Clin Pharmacol Ther. 2021 Jan;109(1):73-81. doi: 10.1002/cpt.2028. Epub 2020 Oct 8. Clin Pharmacol Ther. 2021. PMID: 32869281 Free PMC article. Review.

2

Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?

McGann PT, Ware RE. McGann PT, et al. Curr Opin Hematol. 2011 May;18(3):158-65. doi: 10.1097/MOH.0b013e32834521dd. Curr Opin Hematol. 2011. PMID: 21372708 Free PMC article. Review.

3

Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure.

McGann PT, Howard TA, Flanagan JM, Lahti JM, Ware RE. McGann PT, et al. Br J Haematol. 2011 Jul;154(1):134-40. doi: 10.1111/j.1365-2141.2011.08698.x. Epub 2011 May 4. Br J Haematol. 2011. PMID: 21542824 Free PMC article.

4

Current management of sickle cell anemia.

McGann PT, Nero AC, Ware RE. McGann PT, et al. Cold Spring Harb Perspect Med. 2013 Aug 1;3(8):a011817. doi: 10.1101/cshperspect.a011817. Cold Spring Harb Perspect Med. 2013. PMID: 23709685 Free PMC article.

5

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

McGann PT, Tshilolo L, Santos B, Tomlinson GA, Stuber S, Latham T, Aygun B, Obaro SK, Olupot-Olupot P, Williams TN, Odame I, Ware RE; REACH Investigators. McGann PT, et al. Pediatr Blood Cancer. 2016 Jan;63(1):98-104. doi: 10.1002/pbc.25705. Epub 2015 Aug 14. Pediatr Blood Cancer. 2016. PMID: 26275071 Free PMC article.

6

Hydroxyurea therapy for sickle cell anemia.

McGann PT, Ware RE. McGann PT, et al. Expert Opin Drug Saf. 2015;14(11):1749-58. doi: 10.1517/14740338.2015.1088827. Epub 2015 Sep 14. Expert Opin Drug Saf. 2015. PMID: 26366626 Free PMC article. Review.

7

A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.

McGann PT, Grosse SD, Santos B, de Oliveira V, Bernardino L, Kassebaum NJ, Ware RE, Airewele GE. McGann PT, et al. J Pediatr. 2015 Dec;167(6):1314-9. doi: 10.1016/j.jpeds.2015.08.068. Epub 2015 Oct 23. J Pediatr. 2015. PMID: 26477868 Free PMC article.

8

Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.

McGann PT, Schaefer BA, Paniagua M, Howard TA, Ware RE. McGann PT, et al. Am J Hematol. 2016 Feb;91(2):205-10. doi: 10.1002/ajh.24232. Epub 2015 Nov 26. Am J Hematol. 2016. PMID: 26537622 Free PMC article.

9

Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.

Dong M, McGann PT, Mizuno T, Ware RE, Vinks AA. Dong M, et al. Among authors: mcgann pt. Br J Clin Pharmacol. 2016 Apr;81(4):742-52. doi: 10.1111/bcp.12851. Epub 2016 Feb 5. Br J Clin Pharmacol. 2016. PMID: 26615061 Free PMC article.

10

Improving survival for children with sickle cell disease: newborn screening is only the first step.

McGann PT. McGann PT. Paediatr Int Child Health. 2015;35(4):285-6. doi: 10.1080/20469047.2015.1109255. Paediatr Int Child Health. 2015. PMID: 26744151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page